InnoCare Pharma and KeyMed Biosciences have entered into an exclusive license agreement with Prolium Bioscience for the development and commercialization of the bispecific antibody ICP-B02, which targets tumor cells and T cells to enhance cancer treatment.
Company Information
Company
InnoCare Pharma
Location
Beijing, Beijing, China
About
InnoCare Pharma is a leading biopharmaceutical company that focuses on the treatment of cancer and autoimmune diseases. The company is committed to discovering, developing, and commercializing first-in-class and best-in-class drugs to address unmet medical needs in China and globally. With branches in various cities including Beijing and Hong Kong, InnoCare is actively involved in advancing innovative therapies. They aim to improve the quality of life for patients suffering from serious health conditions.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment InnoCare Pharma ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.